Table 1.

Descriptive data of the 20 operated patients.

Age at diagnosis	Gender	Preoperative KPS (%)	Berger Sanai classification	Preoperative volume (cm3)	Postoperative volume (cm3)	Extent of resection (%)	Tumor type	WHO grade	Postoperative treatment	Early postoperative adverse event	KPS at discharge	KPS at 3 months	Neuropsychological evolution at 3 months
27	F	100	1	9.9	0	100	Oligodendroglioma	2	MRI follow-up	–	100	100	Stable
46	M	90	4	41.4	4.6	89	Glioblastoma	4	Radio-chemotherapy	–	90	100	Stable
24	F	90	4	41.5	3.0	93	Anaplastic astrocytoma	3	Radio-chemotherapy	–	90	70	Stable
40	F	90	1 + 4	42.8	4.0	91	Astrocytoma	2	MRI follow-up	–	90	90	Stable
29	M	90	1 + 2	113.9	6.3	94	Oligoastrocytoma	2	MRI follow-up	–	90	100	Stable
44	F	90	2 + 3	80.1	6.1	92	Oligoastrocytoma	2	MRI follow-up	–	90	90	Improvement
48	M	100	1	33.5	3.7	89	Oligodendroglioma	2	Chemotherapy	–	80	90	Stable
33	M	90	4	47.7	1.3	97	Oligoastrocytoma	2	MRI follow-up	Deshinibition	90	90	Stable
32	F	90	1 + 4	98.1	0	100	Astrocytoma	2	MRI follow-up	Apragmatism psychomotor slowdown	80	100	Stable
29	M	90	1	69.0	1.0	99	Astrocytoma	3	MRI follow-up	Diabetes insipidus	80	100	Stable
34	F	100	1	60.0	0	100	Anaplastic oligoastrocytoma	3	Radiotherapy	Left hemiparesis, awakening delay	50	90	Decrease
29	F	100	1 + 4	28.2	0.3	99	Oligodendroglioma	2	MRI follow-up	Transient hemiplegia	80	90	Stable
41	M	90	1 + 2	111.8	13.6	88	Oligodendroglioma	2	Radiotherapy	Pressure ulcer	90	90	Stable
41	M	90	1	144.1	0	100	Glioblastoma	4	Radio-chemotherapy	–	100	90	Stable
42	F	90	Giant	178.0	15.5	91	Glioblastoma	4	Radio-chemotherapy	–	100	100	Stable
56	M	90	1	54.6	12.6	77	Oligodendroglioma	3	Radio-chemotherapy	–	100	90	Stable
27	M	90	Giant	150.5	27	82	Astrocytoma	2	MRI follow-up	Awakening delay, left arm paresis	90	100	Stable
45	M	90	3 + 4	43.0	5.4	88	Oligodendroglioma	2	Chemotherapy	–	100	100	Improvement
33	M	90	1 + 4	121.5	38.2	69	Astrocytoma	2	MRI follow-up	Transient hemiparesia	80	90	Decrease
32	M	90	Giant	211	26.3	88	Glioblastoma	4	Radio-chemotherapy	–	90	80	Decrease